Cultivated Biosciences develops a creamy ingredient from GMO-free yeast which offers the creaminess needed for plant-based dairy. A group of experienced VCs and angels has invested in the seed round.
Cultivated Biosciences’ mission is to change the way the world thinks about alternative fats within the dairy category. From their labs in Zurich, they are developing a creamy ingredient from GMO-free yeast which offers the creaminess needed for plant-based dairy. This ingredient has a clean label and sustainable production process.
In 2023, Cultivated Biosciences will start testing its creamy ingredient with selected clients for high-value savory applications and are open to interested partners.
The seed round was led by the Swiss investor Wingman Ventures alongside other leading foodtech VC investors such as Big Idea Ventures and Proveg International. In addition, impact investor Blue Horizon and a group of angel investors from the industry participated in the round; industry leaders such as the Founder & CEO of EVERY Arturo Elizondo, the Co-Founder of Planted Lukas Böni, and other angels within the FoodHack syndicate.
Tomas Turner, Co-Founder and CEO of Cultivated Biosciences, said: “We are beyond excited to build a solution that will elevate the mouthfeel of the plant-based dairy category and ensure that it’s simply better and cheaper than its factory-farmed equivalent.”
Robert Boer, Director at Blue Horizon, said: “Cultivated Biosciences is tackling a very important bottleneck in the adoption of plant-based dairy. We want our yoghurts, ice creams and spreads really creamy without compromising taste and mouthfeel. Combining scalable and cost-effective fermentation technology with mission-driven founders makes us very excited to support this Swiss company located in our HQ’s backyard.”
(Press release / SK)
Photo: Cultivated Biosciences Founders Dimitri Zogg (left), Tomas Turner.
Please login or sign up to comment.
Commenting guidelines